John Paul Shen
@jpshen_md
Followers
333
Following
710
Statuses
159
Physician-Scientist at MD Anderson Cancer Center. Combining computational and experimental approaches to advance the treatment of Colon and Appendiceal cancer.
Texas Medical Center, Houston
Joined August 2019
RT @VivekSubbiah: Not every day oncologists get featured in Times Square. Truly an honor. Grateful to @larvol @brunolarvol for the recognit…
0
4
0
RT @OncoDailyGI: BOT/BAL in chemotherapy refractory MSS mCRC with no active liver metastases - Benny Johnson @ASCO @mgfakih
https://t.co/…
0
2
0
RT @Aiims1742: Straight from #GI25 in @NatureMedicine By @skopetz @CathyEngMD & colleagues Encorafenib, cetuximab and chemotherapy in BRA…
0
18
0
RT @PavlosMsaouel: 1/5 Thrilled to share in @NatureComms the clinical outcomes and scRNA-seq correlatives our phase I triplet immunotherapy…
0
47
0
RT @SounakSahu: Excited to share our latest study in @Nature! We used a humanized-mouse ES cell model to explore the functional consequence…
0
26
0
@NEJM It’s great that MSI-H CRC responds well to immune therapy, but it is misleading (especially to patients) and inappropriate to say this was a study of metastatic CRC. MSI-H CRC is fundamentally a different disease than MSS
0
0
8
@Aiims1742 Agree - does not seem that there is equipoise giving traditional chemo to MSI-H CRC patients.
0
0
1
RT @AaronGoodman33: Enroll on SPOTLIGHT. Any center can enroll. The goal is to prove we can safely watch patients with smoldering myeloma…
0
36
0
@NicholasZaorsky @DrUddiGoswami @AJCCancer @NCCN @IntJCanc @uicc @DrSaraGarrett @EricLehrer @DavidDeGraff5 @DrSpratticus @DanTrifMD @AmarUKishan @TimShowalter1 @HenryParkMD @mwang_cwru Interesting study - but what about peritoneal metastasis? Or ovary?
0
0
0
RT @OncoAlert: Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trial out…
0
15
0
@acpmpresearch @kturaga @AtriumHealthWFB @AtriumHealth @LevineCancer @drholowatyj @huntsmancancer @UofUHealth @YaleCancer @YaleMed @MikeFooteMD @MikeWhiteMD @ArdamanShergil1 @JosephMisdraji @VUMC_Cancer Amazing event. Learned so much
0
0
3
@NCIEytanRuppin @PavlosMsaouel Looks very impressive- is the code open source? Would love to apply to appendix cancer where outcomes are strongly correlated with histology
0
0
2
0
0
1